Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
114 EUR | +0.13% | -.--% | -.--% |
04-11 | U.S. Futures Down, European Stocks Mixed | DJ |
04-08 | DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital. | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- With an expected P/E ratio at 58.69 and 35.13 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Consumer Goods Conglomerates
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 29.82B | A | ||
0.00% | 239B | - | C | |
+29.31% | 178B | B | ||
-7.66% | 126B | B- | ||
+32.50% | 79.32B | B+ | ||
-4.27% | 74.17B | B | ||
-15.67% | 50.82B | C+ | ||
-24.68% | 38.6B | - | - | |
+19.71% | 31.74B | A | ||
+63.27% | 28.73B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock
- Ratings Koninklijke DSM